Galmed Pharmaceuticals Ltd.
GLMD
$1.56
$0.000.28%
NASDAQ
06/30/2025 | 03/31/2025 | 06/30/2024 | 06/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -126.00% | 65.60% | 12.24% | 12.24% | 12.24% |
Total Depreciation and Amortization | -- | -- | 722.22% | 722.22% | 722.22% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 667.95% | -95.73% | -22.08% | -22.08% | -22.08% |
Change in Net Operating Assets | 545.39% | 75.98% | 87.19% | 87.19% | 87.19% |
Cash from Operations | -8.65% | 40.73% | 44.43% | 44.43% | 44.43% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -1,877.92% | 93.49% | 222.22% | 222.22% | 222.22% |
Cash from Investing | -1,877.92% | 93.49% | 222.22% | 222.22% | 222.22% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 298.61% | 237.95% | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 298.61% | 237.95% | -- | -- | -- |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 70.69% | 102.29% | 126.82% | 126.82% | 126.82% |